ORYZON announces U.S. patent grant for vafidemstat in borderline personality disorder (BP... 08/07/2026 Healthcare Rare diseases Innovative drugs Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD. Partners - Oryzon Genomics
ORYZON raises €12 million and signs a financing agreement with COFIDES to strengthen its ... 03/07/2026 Healthcare Innovative drugs Financing Priced at €2.70 per share, representing a 14.15% discount on the five day VWAP and a 12.68% discount to the June 30... Partners - Oryzon Genomics
Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck C... 30/06/2026 Healthcare Access to innovation Innovative drugs Prolonged overall survival (OS) was observed in heavily pre-treated refractory Head & Neck Squamous Cell Carcinoma... Partners - THERIVA BIOLOGICS S.L.
Abilitypharma's Ibrilatazarwill be tested for the first time in pediatric neuroblastoma as... 29/06/2026 Healthcare Innovative drugs EU projects Partners - Ability Pharmaceuticals
World ALS Day | “ALS research is currently going through a particularly promising moment” 21/06/2026 Healthcare Rare diseases Innovative drugs Personalized medicine We interview Alfonso de Egaña Barrenechea, CEO of Molefy Pharma, a company developing AP-2, an innovative molecule... AseBio - MOLEFY PHARMA
Research on the TDP-43 protein opens new therapeutic avenues for ALS 20/06/2026 Biotechnology is driving new strategies to combat ALS, including research on the TDP-43 protein, a key target involved... AseBio
The University of Barcelona Science Park reaches a new investment record of €230 million ... 16/06/2026 Healthcare Innovative drugs Financing The University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in 2025, with a total of... Partners - Parc Científic de Barcelona
Shilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Thera... 16/06/2026 Healthcare Rare diseases Innovative drugs Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for a 30.4% equity stake... Partners - Gate2Brain
Stablepharma and AFT Move to Expand Fridge-Free Vaccine Distribution Following Positive Cl... 15/06/2026 Healthcare Innovative drugs International Potential agreement follows positive clinical and stability data, supporting rollout in UK, Canada, Australia and New... Partners - STABLEPHARMA
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia ... 11/06/2026 Healthcare Drug discovery Innovative drugs In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity... Partners - Oryzon Genomics
